美股市場個股詳情
KNSA Kiniksa Pharmaceuticals International
- 25.200
- -1.090-4.15%
收盤價 07/24 16:00 (美東)
- 25.150
- -0.050-0.20%
盤後 18:16 (美東)
17.91億總市值-168000市盈率TTM
26.559最高價24.845最低價97.13萬股成交量26.000今開26.290昨收2478.90萬成交額6.84%換手率126.00市盈率(靜)7108.23萬總股本27.88052周最高4.12市淨率3.58億流通值14.12052周最低--股息TTM1419.36萬流通股32.880歷史最高--股息率TTM6.52%振幅5.010歷史最低25.521平均價1股每手
Kiniksa Pharmaceuticals International關鍵統計數據
季報+年報
顯示同比
| (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | (Q3)2022/09/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | 51.99%1.09億 | 65.18%7,985.8萬 | 22.74%2.7億 | 34.76%8,339.5萬 | -32.37%6,704.6萬 | 164.99%7,147.3萬 | 50.19%4,834.5萬 | 471.24%2.2億 | 230.14%6,188.4萬 | 719.64%9,913.5萬 |
| 營業收入 | 51.99%1.09億 | 65.18%7,985.8萬 | 22.74%2.7億 | 34.76%8,339.5萬 | -32.37%6,704.6萬 | 164.99%7,147.3萬 | 50.19%4,834.5萬 | 471.24%2.2億 | 230.14%6,188.4萬 | 719.64%9,913.5萬 |
| 主營業務成本 | -43.18%1,232.2萬 | 104.80%3,138.4萬 | 45.91%3,340.7萬 | -204.92%-3,000.1萬 | 128.37%2,639.9萬 | 149.22%2,168.5萬 | 22.86%1,532.4萬 | 151.59%2,289.5萬 | -354.43%-983.9萬 | 317.78%1,156萬 |
| 毛利 | 93.44%9,630.9萬 | 46.80%4,847.4萬 | 20.06%2.37億 | 58.10%1.13億 | -53.59%4,064.7萬 | 172.50%4,978.8萬 | 67.48%3,302.1萬 | 570.03%1.97億 | 382.07%7,172.3萬 | 838.84%8,757.5萬 |
| 營業費用 | 82.14%9,642.6萬 | 47.04%6,501.6萬 | 39.75%2.62億 | 72.54%1.13億 | 25.30%5,157.4萬 | 40.66%5,294.2萬 | 2.75%4,421.7萬 | 0.77%1.88億 | 28.75%6,567.6萬 | 2.92%4,116.2萬 |
| 銷售和管理費用 | 45.31%4,239.5萬 | 33.18%3,868.2萬 | 32.13%1.29億 | 35.00%3,673.9萬 | 39.68%3,446.8萬 | 22.37%2,917.5萬 | 30.73%2,904.5萬 | 13.97%9,795.1萬 | 19.67%2,721.5萬 | 18.87%2,467.7萬 |
| 研發費用 | 1.05%2,401.7萬 | 73.57%2,633.4萬 | 16.20%7,609.7萬 | 39.35%2,005.2萬 | 3.77%1,710.6萬 | 72.25%2,376.7萬 | -27.12%1,517.2萬 | -34.05%6,549萬 | -47.54%1,439萬 | -14.30%1,648.5萬 |
| 其他營業費用 | --3,001.4萬 | ---- | 134.82%5,652.4萬 | ---- | ---- | ---- | ---- | 2,782.75%2,407.1萬 | ---- | ---- |
| 營業利潤 | 96.29%-11.7萬 | -47.75%-1,654.2萬 | -357.81%-2,519.6萬 | -98.66%8.1萬 | -123.54%-1,092.7萬 | 83.72%-315.4萬 | 51.99%-1,119.6萬 | 106.24%977.3萬 | 116.74%604.7萬 | 251.35%4,641.3萬 |
| 淨非營業利息收入（費用） | ||||||||||
| 其他淨收入（費用） | 26.42%242.1萬 | 23.69%226.6萬 | 581.88%854.4萬 | 198.36%236.9萬 | 654.04%242.8萬 | 1,759.22%191.5萬 | 5,288.24%183.2萬 | 1,191.75%125.3萬 | 79.4萬 | 32.2萬 |
| 其他非經營收入（費用） | 26.42%242.1萬 | 23.69%226.6萬 | 581.88%854.4萬 | 198.36%236.9萬 | 654.04%242.8萬 | 1,759.22%191.5萬 | 5,288.24%183.2萬 | 1,191.75%125.3萬 | --79.4萬 | --32.2萬 |
| 稅前利潤 | 285.96%230.4萬 | -52.46%-1,427.6萬 | -251.02%-1,665.2萬 | -64.19%245萬 | -118.19%-849.9萬 | 93.57%-123.9萬 | 59.79%-936.4萬 | 107.04%1,102.6萬 | 118.97%684.1萬 | 252.42%4,673.5萬 |
| 所得稅 | 138.32%621.2萬 | 17.96%342.8萬 | 82.17%-3,073.6萬 | -1,057.44%-2,278.7萬 | 103.02%535.6萬 | -2,364.11%-1,621.1萬 | 50.96%290.6萬 | -12,543.10%-1.72億 | 753.05%238萬 | -150,203.39%-1.77億 |
| 除稅後利潤 | -126.10%-390.8萬 | -44.29%-1,770.4萬 | -92.32%1,408.4萬 | 465.73%2,523.7萬 | -106.18%-1,385.5萬 | 174.93%1,497.2萬 | 51.33%-1,227萬 | 216.11%1.83億 | 112.28%446.1萬 | 833.67%2.24億 |
| 持續經營利潤 | -126.10%-390.8萬 | -44.29%-1,770.4萬 | -92.32%1,408.4萬 | 465.73%2,523.7萬 | -106.18%-1,385.5萬 | 174.93%1,497.2萬 | 51.33%-1,227萬 | 216.11%1.83億 | 112.28%446.1萬 | 833.67%2.24億 |
| 歸屬於少數股東的淨利潤 | ||||||||||
| 歸屬於母公司的淨利潤 | -126.10%-390.8萬 | -44.29%-1,770.4萬 | -92.32%1,408.4萬 | 465.73%2,523.7萬 | -106.18%-1,385.5萬 | 174.93%1,497.2萬 | 51.33%-1,227萬 | 216.11%1.83億 | 112.28%446.1萬 | 833.67%2.24億 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | ||||||||||
| 歸屬於普通股股東的淨利潤 | -126.10%-390.8萬 | -44.29%-1,770.4萬 | -92.32%1,408.4萬 | 465.73%2,523.7萬 | -106.18%-1,385.5萬 | 174.93%1,497.2萬 | 51.33%-1,227萬 | 216.11%1.83億 | 112.28%446.1萬 | 833.67%2.24億 |
| 基本每股收益 | -128.57%-0.06 | -38.89%-0.25 | -92.42%0.2 | 500.00%0.36 | -106.19%-0.2 | 172.41%0.21 | 50.00%-0.18 | 214.78%2.64 | 111.32%0.06 | 834.09%3.23 |
| 稀釋每股收益 | -128.57%-0.06 | -38.89%-0.25 | -92.31%0.2 | 483.33%0.35 | -106.29%-0.2 | 172.41%0.21 | 50.00%-0.18 | 213.04%2.6 | 111.32%0.06 | 822.73%3.18 |
| 每股派息 | ||||||||||
| 貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| 審計意見 | -- | -- | 無保留意見 | -- | -- | -- | -- | -- | -- | -- |
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
